Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Cash from Investing Activities (2011 - 2013)

Updated

Kazia Therapeutics (KZIA) reported Cash from Investing Activities of -$1.64 million for FY2022 (year ended Dec 31, 2022), compared with -$1.19 million in FY2021.

Analysis

Kazia Therapeutics (KZIA) Cash from Investing Activities (2011 - 2013) Analysis & Trends

Dating back to FY2009, Kazia Therapeutics' Cash from Investing Activities record includes 13 fiscal years.

  • The FY2022 figure ranks as the lowest annual Cash from Investing Activities since FY2017.
  • According to Business Quant data, Cash from Investing Activities came in at -$1.19 million in FY2021, $1.64 million in FY2019 and $112,181 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -8.30 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -2.71 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -10.22 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -1.32 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -1.89 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -649.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -244.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -2.03 Bn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -1,855.54
Aug 30, 2013 -2.18 Mn
Jun 30, 2013 -1,986.88
Dec 31, 2011 52,574.61
API Access

Kazia Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=KZIA&period=max&api_key=YOUR_API_KEY